We’ve often heard about the use of immunotherapy when it comes to cancer treatment, and while we’ve seen incredible advances, there remains more to be done. Not all cancers can be treated by immunotherapy, and not all patients respond to it as well. As researchers continue to develop and study potential immunotherapies to treat cancers, what if a new test could help them track how effective these therapies are in real-time? Here to tell us more about that is Assistant Professor Dr Anthony Tan, from the Emerging Infectious Diseases Programme at the Duke-NUS Medical School.

Image credit: Shutterstock